Please login to the form below

Not currently logged in
Email:
Password:

SOBI

This page shows the latest SOBI news and features for those working in and with pharma, biotech and healthcare.

FDA clears Sobi’s Gamifant for ‘hyper-inflammation’ disease

FDA clears Sobi’s Gamifant for ‘hyper-inflammation’ disease

Approval adds to growing US portfolio. Swedish Orphan Biovitrum (Sobi) has the US approval it sought for Gamifant, an ultra-rare disease therapy it licensed from Novimmune for $452m a few ... Earlier this month, Sobi agreed to acquire the US rights to

Latest news

More from news
Approximately 7 fully matching, plus 11 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest appointments

  • BMS appoints new commercial leader, Davies joins Eisai and more BMS appoints new commercial leader, Davies joins Eisai and more

    Sobi appoints head of technical operations. Rare disease specialist company Sobi has appointed Anne Marie de Jonge Schuermans to front its new technical operations organisation. ... operations. She joins Sobi from Biogen, where she served as vice

  • Sobi poaches Pfizer’s Fredrick Wetterlundh Sobi poaches Pfizer’s Fredrick Wetterlundh

    Swedish Orphan Biovitrum (Sobi) has appointed Fredrik Wetterlundh as head of human resources and will simultaneously be part of Sobi’s extended leadership team. ... Guido Oelkers, CEO and president of Sobi, said: “His experience from the

  • Mereo BioPharma appoints head of patient access and commercial planning Mereo BioPharma appoints head of patient access and commercial planning

    Wills Hughes-Wilson joins the group from Sobi. London, UK-based Mereo BioPharma, has strengthened its team with the addition of Wills Hughes-Wilson, who joins the biopharma as its new ... In this role, Hughes-Wilson was responsible for Sobi’s

  • Sobi names Holly May VP of sales and marketing, US Sobi names Holly May VP of sales and marketing, US

    Rare disease firm Sobi has appointed Holly May as its new vice president of sales and marketing for the US. ... May’s new role will see her lead the biopharma’s commercial team in bringing Sobi’s medicines to the country.

  • Relay Therapeutics appoints Sarah O’Brien as VP of HR Relay Therapeutics appoints Sarah O’Brien as VP of HR

    She joins the biotech from Sobi. Relay Therapeutics, a biotech based in the US, has appointed its new vice president of human resources in the form of Sarah O’Brien. ... She joins the biotech from Sobi in North America, where she was responsible for a

More from appointments
Approximately 9 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...

Infographics